实脾饮加减治疗晚期肝癌腹水的临床疗效观察

Efficacy of Shipi Yin on ascites from hepatic cancer at later period

目的:探讨实脾饮加减治疗晚期肝癌腹水的临床疗效。方法:将2016年1月-2017年2月120例晚期肝癌腹水患者作为对象,依据处理方法差异分为对照组、实脾饮组,各有60例。对照组常规给予利尿剂、护肝药物和退黄药物进行治疗,实脾饮组在对照组基础上给予实脾饮加减治疗。比较两组晚期肝癌腹水治疗总有效率;晚期肝癌腹水完全消退时间、平均住院时间;治疗前后Child-Pugh水平和肝功能指标。结果:实脾饮组晚期肝癌腹水治疗总有效率高于对照组,P<0.05;实脾饮组晚期肝癌腹水完全消退时间、平均住院时间短于对照组,P<0.05;干预前两组Child-Pugh水平和肝功能指标相近,P>0.05;干预后实脾饮组Child-Pugh水平和肝功能指标优于对照组,P<0.05。结论:实脾饮加减治疗晚期肝癌腹水的临床疗效确切,可加速腹水消退,缩短疗程,减轻临床症状,改善患者肝功能,值得推广。

Objective： To investigate the clinical efficacy of Shipi Yin（ 实脾饮） on ascites from hepatic cancer at later period. Methods： 120 patients were selected as subjects. According to the differences in treatment methods, they were divided into the control group and Shipi Yin group（ 实脾饮组）, 60 cases in each. The control group was treated with diuretics, liver protection drugs and jaundice drugs. The Shipi Yin group was treated with Shipi Yin more. Results： The total efficacy in the Shipi Yin group was higher, P〈0.05; the time of complete elimination of ascites and the average length of hospital stay were shorter in the Shipi Yin group, P〈0.05. Child-Pugh levels and liver function were better in the Shipi Yin group, P〈0.05. Conclusion： Shipi Yin on ascites from hepatic cancer at later period was effective, by accelerating the regression of ascites, shortening the course of treatment, reducing the clinical symptoms and improving the liver function, and is worth promoting.